- Home
- TRUP vs CPRX Comparison
TRUP vs CPRX Comparison
Compare TRUP & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUP
- CPRX
- Stock Information
- Founded
- TRUP 2000
- CPRX 2002
- Country
- TRUP United States
- CPRX United States
- Employees
- TRUP N/A
- CPRX N/A
- Industry
- TRUP Medical Specialities
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- TRUP Health Care
- CPRX Health Care
- Exchange
- TRUP Nasdaq
- CPRX Nasdaq
- Market Cap
- TRUP 2.3B
- CPRX 2.5B
- IPO Year
- TRUP 2014
- CPRX 2006
- Fundamental
- Price
- TRUP $47.63
- CPRX $22.78
- Analyst Decision
- TRUP Buy
- CPRX Strong Buy
- Analyst Count
- TRUP 7
- CPRX 7
- Target Price
- TRUP $45.33
- CPRX $32.86
- AVG Volume (30 Days)
- TRUP 565.6K
- CPRX 1.4M
- Earning Date
- TRUP 02-13-2025
- CPRX 02-26-2025
- Dividend Yield
- TRUP N/A
- CPRX N/A
- EPS Growth
- TRUP N/A
- CPRX 114.68
- EPS
- TRUP N/A
- CPRX 1.18
- Revenue
- TRUP $1,244,234,000.00
- CPRX $460,482,000.00
- Revenue This Year
- TRUP N/A
- CPRX $23.98
- Revenue Next Year
- TRUP $7.10
- CPRX $18.27
- P/E Ratio
- TRUP N/A
- CPRX $19.33
- Revenue Growth
- TRUP 17.52
- CPRX 32.17
- 52 Week Low
- TRUP $19.69
- CPRX $13.12
- 52 Week High
- TRUP $57.90
- CPRX $24.27
- Technical
- Relative Strength Index (RSI)
- TRUP 46.20
- CPRX 56.81
- Support Level
- TRUP $42.33
- CPRX $21.23
- Resistance Level
- TRUP $49.59
- CPRX $23.26
- Average True Range (ATR)
- TRUP 2.24
- CPRX 1.14
- MACD
- TRUP 0.04
- CPRX 0.20
- Stochastic Oscillator
- TRUP 61.63
- CPRX 74.85
About TRUP Trupanion Inc.
Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue primarily from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.